MiR-30a sensitized lung cancer against neoadjuvant chemotherapy by depressing autophagy
ConclusionsIntentionally elevating miR-30a expression was conducive to improving NSCLC prognosis after neoadjuvant chemotherapy, for its depressing drug-caused autophagy and resistance.
Source: Japanese Journal of Clinical Oncology - Category: Cancer & Oncology Source Type: research
More News: Alimta | Cancer | Cancer & Oncology | Chemotherapy | Japan Health | Lung Cancer | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Non-Small Cell Lung Cancer | Study